Next, we analysed GCNT1 gene expression in primary prostate cancer tissue samples from the TCGA PRAD clinical cohort (n = 493), and identified tumours with high (n = 124) and low (n = 123) GCNT1 expression31,35,36. This evidence concerns the gene GCNT1 and prostate cancer.